Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$244.61 - $310.48 $9.78 Million - $12.4 Million
-40,000 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$198.21 - $248.9 $6.7 Million - $8.41 Million
-33,800 Reduced 45.8%
40,000 $9.94 Million
Q3 2021

Nov 15, 2021

SELL
$188.42 - $208.66 $6.41 Million - $7.09 Million
-34,000 Reduced 31.54%
73,800 $14.7 Million
Q2 2021

Aug 13, 2021

BUY
$184.89 - $202.68 $7.94 Million - $8.7 Million
42,933 Added 66.19%
107,800 $20.6 Million
Q1 2021

May 14, 2021

SELL
$169.52 - $196.53 $18.5 Million - $21.4 Million
-109,130 Reduced 62.72%
64,867 $12.7 Million
Q4 2020

Feb 16, 2021

BUY
$143.79 - $183.66 $5.01 Million - $6.4 Million
34,821 Added 25.02%
173,997 $30.3 Million
Q3 2020

Nov 16, 2020

BUY
$140.89 - $159.9 $9.93 Million - $11.3 Million
70,492 Added 102.63%
139,176 $20.7 Million
Q2 2020

Aug 14, 2020

BUY
$125.49 - $164.68 $8.62 Million - $11.3 Million
68,684 New
68,684 $10.5 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $75.6B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Point State Capital LP Portfolio

Follow Point State Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Point State Capital LP with notifications on news.